Atlas Trials

Pharmacogenetics of SGLT2 Inhibitors

Clinical trial NCT02462421 · TERMINATED

Trial details

NCT number
NCT02462421
Sponsor
University of Maryland, Baltimore
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes MellitusGoutHyperuricemia
Start date
2015-06-01
Primary completion
2021-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.